ERBB3 and breast cancer: HER3 protein overexpression has been shown to commonly co-occur with HER2 gene amplification and HER2 overexpression, therefore, HER3 is thought to contribute markedly to the pathogenesis of HER2-amplified breast cancer subtype [4, 13, 14].